We are live on ! Find out more
UBS AM

UBS AM Portfolio holdings

AUM $481B
1-Year Est. Return 26.39%
 

UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.

This Fund
S&P 500
This Quarter Est. Return
+2.96%
1 Year Est. Return
+26.39%
3 Year Est. Return
+93.76%
5 Year Est. Return
+124.47%
10 Year Est. Return
+503.87%
AUM
$88.5B
AUM Growth
+$2.22B
Cap. Flow
-$721M
Cap. Flow %
-0.82%
Top 10 Hldgs %
14.33%
Holding
2,695
New
65
Increased
1,198
Reduced
577
Closed
89

Top Buys

Rank Stock Value
1
SPGI icon
S&P Global
SPGI
+$205M
2
JNJ icon
Johnson & Johnson
JNJ
+$186M
3
HON icon
Honeywell
HON
+$177M
4
MDLZ icon
Mondelez International
MDLZ
+$132M
5
BABA icon
Alibaba
BABA
+$130M

Sector Composition

Rank Sector Weight
1 Healthcare 15.89%
2 Technology 14.47%
3 Financials 12.9%
4 Consumer Discretionary 10.06%
5 Communication Services 8.98%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ARDX icon
2526
Ardelyx
ARDX
$1.25B
$90K ﹤0.01%
10,300
DAKT icon
2527
Daktronics
DAKT
$947M
$89K ﹤0.01%
14,298
CSLT
2528
DELISTED
CASTLIGHT HEALTH, INC.
CSLT
$86K ﹤0.01%
21,800
SSI
2529
DELISTED
Stage Stores Inc
SSI
$84K ﹤0.01%
17,200
IMMU
2530
DELISTED
Immunomedics Inc
IMMU
$83K ﹤0.01%
35,692
-10,200
-22% -$34.1K
CONN
2531
DELISTED
Conn's Inc.
CONN
$82K ﹤0.01%
10,900
KRO icon
2532
KRONOS Worldwide
KRO
$711M
$80K ﹤0.01%
15,199
SID icon
2533
Companhia Siderúrgica Nacional
SID
$1.41B
$80K ﹤0.01%
32,799
BCRX icon
2534
BioCryst Pharmaceuticals
BCRX
$2.46B
$77K ﹤0.01%
27,100
KPTI icon
2535
Karyopharm Therapeutics
KPTI
$160M
$70K ﹤0.01%
700
KTOS icon
2536
Kratos Defense & Security Solutions
KTOS
$8.83B
$68K ﹤0.01%
16,697
DNN icon
2537
Denison Mines
DNN
$2.45B
$66K ﹤0.01%
119,893
EPE
2538
DELISTED
EP Energy Corporation
EPE
$57K ﹤0.01%
10,975
UDF
2539
DELISTED
UNITED DEV FDG IV COM SHS OF BENE INT (TX)
UDF
$42K ﹤0.01%
13,082
WAC
2540
DELISTED
Walter Investment Mgt Corp
WAC
$41K ﹤0.01%
14,699
SDRL
2541
DELISTED
Seadrill Limited Common Stock
SDRL
$37K ﹤0.01%
43
-164
-79% -$156K
INFI
2542
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
$30K ﹤0.01%
22,299
GEN
2543
DELISTED
Genesis Healthcare, Inc.
GEN
$24K ﹤0.01%
13,800
ACTG icon
2544
Acacia Research
ACTG
$452M
-20,698
Closed -$78K
AMRC icon
2545
Ameresco
AMRC
$1.05B
-10,197
Closed -$49K
ARCB icon
2546
ArcBest
ARCB
$3.14B
-9,900
Closed -$214K
ASX icon
2547
ASE Group
ASX
$71.4B
-168,555
Closed -$986K
CCEP icon
2548
Coca-Cola Europacific Partners
CCEP
$49.3B
-540,022
Closed -$27.4M
CECO icon
2549
Ceco Environmental
CECO
$3.87B
-11,480
Closed -$71K
CHRS icon
2550
Coherus Oncology
CHRS
$227M
-9,567
Closed -$203K

Similar funds

UBS AM's Q2 2016 Portfolio in Review

As of Q2 2016, UBS AM held 2,695 positions worth $88.5B, up 2.6% from $86.2B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

UBS AM's Q2 2016 filing shows 65 new, 1,198 increased, 577 reduced and 89 closed positions. Its largest new stake was S&P Global: 1,914,020 shares worth $205M. The largest sale was MCGRAW-HILL FINANCIAL INC COM, an estimated $270M.

By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 15% a quarter earlier, followed by Technology and Financials.

  • UBS AM's largest Q2 2016 buy was S&P Global: 1,914,020 shares worth $205M.
  • UBS AM added most to Johnson & Johnson in Q2 2016, an estimated $186M increase.
  • UBS AM's biggest Q2 2016 reduction was Citigroup, cutting an estimated $185M.
  • UBS AM fully exited MCGRAW-HILL FINANCIAL INC COM in Q2 2016, selling an estimated $270M.
  • UBS AM's ten largest holdings make up 14% of its $88.5B portfolio in Q2 2016.
  • UBS AM opened 65 new positions and closed 89 in Q2 2016.
  • UBS AM's portfolio value rose 2.6% quarter-over-quarter to $88.5B.

Based on UBS AM's 13F filing for Q2 2016, filed 9 Aug 2016.